Patents by Inventor Ashok Bhausaheb Kadam

Ashok Bhausaheb Kadam has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Fused pyrimidine-dione derivatives as TRPA1 modulators
    Patent number: 9000159
    Abstract: The invention described herein relates to novel fused pyrimidinediones derivatives of formula (I) which are TRPA (Transient Receptor Potential subfamily A) modulators. In particular, compounds described herein are useful for treating or preventing diseases, conditions and/or disorders modulated by TRPA1 (Transient Receptor Potential subfamily A, member 1). This invention also provides processes for preparing compounds described herein, intermediates used in their synthesis, pharmaceutical compositions thereof, and methods for treating or preventing diseases, conditions and/or disorders modulated by TRPA1.
    Type: Grant
    Filed: November 14, 2013
    Date of Patent: April 7, 2015
    Assignee: Glenmark Pharmaceuticals S.A.
    Inventors: Sachin Sundarlal Chaudhari, Sukeerthi Kumar, Abraham Thomas, Nisha Parag Patil, Ashok Bhausaheb Kadam, Vishal Govindrao Deshmukh, Sachin Vasantrao Dhone, Rajendra Prakash Chikhale, Neelima Khairatkar-Joshi, Indranil Mukhopadhyay
  • FUSED PYRIMIDINE-DIONE DERIVATIVES AS TRPA1 MODULATORS
    Publication number: 20140128603
    Abstract: The invention described herein relates to novel fused pyrimidinediones derivatives of formula (I) which are TRPA (Transient Receptor Potential subfamily A) modulators. In particular, compounds described herein are useful for treating or preventing diseases, conditions and/or disorders modulated by TRPA1 (Transient Receptor Potential subfamily A, member 1). This invention also provides processes for preparing compounds described herein, intermediates used in their synthesis, pharmaceutical compositions thereof, and methods for treating or preventing diseases, conditions and/or disorders modulated by TRPA1.
    Type: Application
    Filed: November 14, 2013
    Publication date: May 8, 2014
    Applicant: Glenmark Pharmaceuticals, S.A.
    Inventors: Sachin Sundarlal Chaudhari, Sukeerthi Kumar, Abraham Thomas, Nisha Parag Patil, Ashok Bhausaheb Kadam, Vishal Govindrao Deshmukh, Sachin Vasantrao Dhone, Rajendra Prakash Chikhale, Neelima Khairatkar-Joshi, Indranil Mukhopadhyay
  • Fused pyrimidine-dione derivatives as TRPA1 modulators
    Patent number: 8623880
    Abstract: The invention described herein relates to novel fused pyrimidinediones derivatives of formula (I) which are TRPA (Transient Receptor Potential subfamily A) modulators. In particular, compounds described herein are useful for treating or preventing diseases, conditions and/or disorders modulated by TRPA1 (Transient Receptor Potential subfamily A, member 1). This invention also provides processes for preparing compounds described herein, intermediates used in their synthesis, pharmaceutical compositions thereof, and methods for treating or preventing diseases, conditions and/or disorders modulated by TRPA1.
    Type: Grant
    Filed: March 17, 2010
    Date of Patent: January 7, 2014
    Assignee: Glenmark Pharmaceuticals S.A.
    Inventors: Sachin Sundarlal Chaudhari, Sukeerthi Kumar, Abraham Thomas, Nisha Parag Patil, Ashok Bhausaheb Kadam, Vishal Govindrao Deshmukh, Sachin Vasantrao Dhone, Rajendra Prakash Chikhale, Neelima Khairatkar-Joshi, Indranil Mukhopadhyay
  • Fused imidazole carboxamides as TRPV3 modulators
    Patent number: 8318928
    Abstract: The present invention provides transient receptor potential vanilloid (TRPV) modulators of formula (I). In particular, compounds described herein are useful for treating or preventing diseases, conditions and/or disorders modulated by TRPV3. Also provided herein are processes for preparing compounds described herein, intermediates used in their synthesis, pharmaceutical compositions thereof, and methods for treating or preventing diseases, conditions and/or disorders modulated by TRPV3.
    Type: Grant
    Filed: December 11, 2009
    Date of Patent: November 27, 2012
    Assignee: Glenmark Pharmaceuticals, S.A.
    Inventors: Sachin Sundarlal Chaudhari, Thomas Abraham, Ashok Bhausaheb Kadam, Sachin Vasantrao Dhone, Suresh Mahadev Kadam, Neelima Khairatkar-Joshi, Vidya Ganapati Kattige
  • FUSED PYRIMIDINE-DIONE DERIVATIVES AS TRPAI MODULATORS
    Publication number: 20120041004
    Abstract: The invention described herein relates to novel fused pyrimidinediones derivatives of formula (I) which are TRPA (Transient Receptor Potential subfamily A) modulators. In particular, compounds described herein are useful for treating or preventing diseases, conditions and/or disorders modulated by TRPA1 (Transient Receptor Potential subfamily A, member 1). This invention also provides processes for preparing compounds described herein, intermediates used in their synthesis, pharmaceutical compositions thereof, and methods for treating or preventing diseases, conditions and/or disorders modulated by TRPA1.
    Type: Application
    Filed: March 17, 2010
    Publication date: February 16, 2012
    Inventors: Sachin Sundarlal Chaudhari, Sukeerthi Kumar, Abraham Thomas, Nisha Parag Patil, Ashok Bhausaheb Kadam, Vishal Govindrao Deshmukh, Sachin Vasantrao Dhone, Rajendra Prakash Chikhale, Neelima Khairatkar-Joshi, Indranil Mukhopadhyay
  • CHROMENONE DERIVATIVES AS TRPV3 ANTAGONISTS
    Publication number: 20110237659
    Abstract: The present invention provides transient receptor potential vanilloid (TRPV) modulators of formula (I). In particular, compounds described herein are useful for treating or preventing diseases, conditions and/or disorders modulated by TRPV3. Also provided herein are processes for preparing compounds described herein, intermediates used in their synthesis, pharmaceutical compositions thereof, and methods for treating or preventing diseases, conditions and/or disorders modulated by TRPV3.
    Type: Application
    Filed: November 6, 2009
    Publication date: September 29, 2011
    Applicant: GLENMARK PHARMACEUTICALS S.A.
    Inventors: Sachin Sundarlal Chaudhari, Abraham Thomas, Ashok Bhausaheb Kadam, Sachin Vasantrao Dhone, Bharat Gangadhar Adik, Neelima Khairatkar-joshi, Vidya Ganapati Kattige
  • Processes for the preparation of DPP IV inhibitors
    Patent number: 7893103
    Abstract: The present invention relates to novel processes for preparing DPP-IV inhibitors having the structure of formula I, and pharmaceutically acceptable salt thereof, which are useful for treatment of Type 2 diabetes.
    Type: Grant
    Filed: June 27, 2007
    Date of Patent: February 22, 2011
    Assignee: Glenmark Pharmaceuticals, S.A.
    Inventors: Abraham Thomas, V. S. Prasada Rao Lingam, Ashok Bhausaheb Kadam, Suresh M. Kadam, Shantaram Kashinath Phatangare, Deepak Vitthal Ukride
  • FUSED IMIDAZOLE CARBOXAMIDES AS TRPV3 MODULATORS
    Publication number: 20100152192
    Abstract: The present invention provides transient receptor potential vanilloid (TRPV) modulators of formula (I). In particular, compounds described herein are useful for treating or preventing diseases, conditions and/or disorders modulated by TRPV3. Also provided herein are processes for preparing compounds described herein, intermediates used in their synthesis, pharmaceutical compositions thereof, and methods for treating or preventing diseases, conditions and/or disorders modulated by TRPV3.
    Type: Application
    Filed: December 11, 2009
    Publication date: June 17, 2010
    Applicant: Glenmark Pharmaceuticals S.A
    Inventors: Sachin Sundarlal Chaudhari, Abraham Thomas, Ashok Bhausaheb Kadam, Sachin Vasantrao Dhone, Suresh Mahdadev Kadam, Neelima Khairatkar-Joshi, Vidya Ganapati Kattige